In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.
Christie Ballantyne is one of the nation’s foremost experts on lipids, atherosclerosis and heart disease prevention. His research interest in the prevention of heart disease has led him to become an established investigator for the American Heart Association and to receive continuous funding from the NIH since joining the faculty in 1988 in basic research of leukocyte-endothelial interactions, translations research in biomarkers and clinical trials.
Over the past 34 years, his many accomplishments have included being elected as Fellow of the American Association for the Advancement of Science, the American Society of Clinical Investigation, and the Association of American Physicians. In 2012 he received the American College of Cardiology Distinguished Scientist Award (Basic Domain). In 2014 and 2015, Thomson Reuters recognized Christie as one of “The World's Most Influential Scientific Minds.”
Read More
A division of Tarsus Medical owned by Tarsus Group
